Cite
NLRP3 agonist enhances radiation-induced immune priming and promotes abscopal responses in anti-PD1 resistant model.
MLA
Barsoumian, Hampartsoum B., et al. “NLRP3 Agonist Enhances Radiation-Induced Immune Priming and Promotes Abscopal Responses in Anti-PD1 Resistant Model.” Cancer Immunology, Immunotherapy, vol. 72, no. 9, Sept. 2023, pp. 3003–12. EBSCOhost, https://doi.org/10.1007/s00262-023-03471-x.
APA
Barsoumian, H. B., He, K., Hsu, E., Bertolet, G., Sezen, D., Hu, Y., Riad, T. S., Cortez, M. A., & Welsh, J. W. (2023). NLRP3 agonist enhances radiation-induced immune priming and promotes abscopal responses in anti-PD1 resistant model. Cancer Immunology, Immunotherapy, 72(9), 3003–3012. https://doi.org/10.1007/s00262-023-03471-x
Chicago
Barsoumian, Hampartsoum B., Kewen He, Ethan Hsu, Genevieve Bertolet, Duygu Sezen, Yun Hu, Thomas S. Riad, Maria Angelica Cortez, and James W. Welsh. 2023. “NLRP3 Agonist Enhances Radiation-Induced Immune Priming and Promotes Abscopal Responses in Anti-PD1 Resistant Model.” Cancer Immunology, Immunotherapy 72 (9): 3003–12. doi:10.1007/s00262-023-03471-x.